序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
1 |
1111941-90-2 |
Bradanicline HCl |
≥98% |
|
询价 |
2 |
893449-38-2 |
BR-1 |
≥98% |
|
询价 |
3 |
73815-11-9 |
Cimoxatone |
≥98% |
|
询价 |
4 |
33404-57-8 |
Dunnione |
≥98% |
|
询价 |
5 |
77-53-2 |
Cedrol |
≥98% |
|
询价 |
6 |
811435-10-6 |
Polymyxin B1-i |
≥98% |
|
询价 |
7 |
156161-89-6 |
BQ788 sodium salt |
≥98% |
|
询价 |
8 |
9002-86-2 |
Polyvinyl chloride |
≥98% |
|
询价 |
9 |
1807512-46-4 |
Mal-PEG5-PFP |
≥98% |
50mg, 100mg, 250mg |
询价 |
10 |
15382-69-1 |
m-Anisidine,4-(3-heptenyloxy)- |
≥98% |
50mg, 100mg, 250mg |
询价 |
11 |
15382-68-0 |
m-Anisidine,4-((3-ethylheptyl)oxy)-,hydrochloride |
≥98% |
50mg, 100mg, 250mg |
询价 |
12 |
15382-66-8 |
m-Anisidine,4-(2-ethylbutoxy)-,hydrobromide |
≥98% |
50mg, 100mg, 250mg |
询价 |
13 |
15382-67-9 |
m-Anisidine,4-((1-methylheptyl)oxy)-,hydrochloride |
≥98% |
50mg, 100mg, 250mg |
询价 |
14 |
109808-49-3 |
m-Anisamide,N-(5-(p-aminophenoxy)pentyl)- |
≥98% |
50mg, 100mg, 250mg |
询价 |
15 |
135306-39-7 |
Manifaxine |
≥98% |
50mg, 100mg, 250mg |
询价 |
16 |
1392-28-5 |
Mandelonitrile primeveroside |
≥98% |
50mg, 100mg, 250mg |
询价 |
17 |
|
MGR1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
18 |
4242-46-0 |
Mandelonitrile benzoate |
≥98% |
50mg, 100mg, 250mg |
询价 |
19 |
90-64-2 |
Mandelic acid |
≥98% |
50mg, 100mg, 250mg |
询价 |
20 |
8018-01-7 |
Mancozeb |
≥98% |
|
询价 |
21 |
102-28-3 |
m-Aminoacetanilide |
≥98% |
50mg, 100mg, 250mg |
询价 |
22 |
60394-92-5 |
Mamanine |
≥98% |
50mg, 100mg, 250mg |
询价 |
23 |
880759-65-9 |
Naloxonazine dihydrochloride |
≥98% |
50mg, 100mg, 250mg |
询价 |
24 |
688013-96-9 |
Malyl tyrosine |
≥98% |
50mg, 100mg, 250mg |
询价 |
25 |
1485456-25-4 |
Mal-RP |
≥98% |
50mg, 100mg, 250mg |
询价 |
26 |
2055048-43-4 |
Mal-PEG8-t-butyl ester |
≥98% |
|
询价 |
27 |
2055033-05-9 |
Mal-PEG8-NHS ester |
≥98% |
50mg, 100mg, 250mg |
询价 |
28 |
1818294-46-0 |
Mal-PEG8-acid |
≥98% |
50mg, 100mg, 250mg |
询价 |
29 |
518044-37-6 |
Mal-PEG6-t-butyl ester |
≥98% |
50mg, 100mg, 250mg |
询价 |
30 |
1599486-33-5 |
Mal-PEG6-PFP |
≥98% |
|
询价 |
31 |
1599472-25-9 |
Mal-PEG6-NHS ester |
≥98% |
50mg, 100mg, 250mg |
询价 |
32 |
518044-42-3 |
Mal-PEG6-acid |
≥98% |
50mg, 100mg, 250mg |
询价 |
33 |
105788-17-8 |
m-Anisidine,4-(4-pentenyloxy)-,hydrobromide |
≥98% |
50mg, 100mg, 250mg |
询价 |
34 |
131505-02-7 |
PD 130908 |
≥98% |
50mg, 100mg, 250mg |
询价 |
35 |
107276-40-4 |
m-Anisidine,4-(3-(p-methoxyphenoxy)propoxy)- |
≥98% |
50mg, 100mg, 250mg |
询价 |
36 |
15382-73-7 |
m-Anisidine,4-(3-phenylpropoxy)- |
≥98% |
50mg, 100mg, 250mg |
询价 |
37 |
15382-87-3 |
m-Anisidine,4-(3-phenoxypropoxy)- |
≥98% |
50mg, 100mg, 250mg |
询价 |
38 |
909664-41-1 |
BPU-11 |
≥98% |
|
询价 |
39 |
1802665-43-5 |
BPTQ |
≥98% |
|
询价 |
40 |
139968-49-3 |
Metaflumizone |
≥98% |
|
询价 |
41 |
26719-50-6 |
1,4-Butanediol bisdecanoate |
≥98% |
|
询价 |
42 |
776-88-5 |
1,3-Dioxane,5,5-dimethyl-2-phenyl- |
≥98% |
|
询价 |
43 |
1120-97-4 |
1,3-Dioxane,4-methyl- |
≥98% |
|
询价 |
44 |
7401-30-1 |
1,3-Dioxane,2-(p-chlorophenyl)-5-methyl-5-nitro- |
≥98% |
|
询价 |
45 |
3080-69-1 |
1,3-Dioxane,2-hexyl-4-methyl- |
≥98% |
|
询价 |
46 |
141434-67-5 |
13-Dihydrodoxorubicin |
≥98% |
|
询价 |
47 |
17863-69-3 |
1,2-Didecanoylglycerol |
≥98% |
|
询价 |
48 |
773852-25-8 |
103D5R |
≥98% |
|
询价 |
49 |
1914989-49-3 |
BPN-15606 |
≥98% |
|
询价 |
50 |
1849590-02-8 |
Tomivosertib HCl(eFT-508) |
≥98% |
|
询价 |
51 |
|
Tomivosertib 2HCl |
≥98% |
|
询价 |
52 |
1059677-12-1 |
BPH-742 |
≥98% |
|
询价 |
53 |
946417-21-6 |
BPH-675 |
≥98% |
|
询价 |
54 |
157124-84-0 |
BPH-652 potassium |
≥98% |
|
询价 |
55 |
39391-39-4 |
Nocardicin A |
≥98% |
|
询价 |
56 |
1059677-40-5 |
BPH-628 |
≥98% |
|
询价 |
57 |
108093-90-9 |
Probimane |
≥98% |
|
询价 |
58 |
1426824-36-3 |
BPH-1218 |
≥98% |
|
询价 |
59 |
1638-41-1 |
p38 MAP Kinase Inhibitor IV |
≥98% |
|
询价 |
60 |
143986-17-8 |
LZN86178 |
≥98% |
|
询价 |